2022
Screening Tool to Identify Patients with Advanced Aortic Valve Stenosis
Yousef S, Amabile A, Ram C, Huang H, Korutla V, Singh S, Agarwal R, Assi R, Milewski RK, Zhang Y, Patel PA, Krane M, Geirsson A, Vallabhajosyula P. Screening Tool to Identify Patients with Advanced Aortic Valve Stenosis. Journal Of Clinical Medicine 2022, 11: 4386. PMID: 35956007, PMCID: PMC9369431, DOI: 10.3390/jcm11154386.Peer-Reviewed Original ResearchAortic stenosisRisk prediction modelTertiary academic care centerAcademic care centerSevere aortic stenosisAortic valve stenosisBody mass indexCross-sectional analysisLogistic regression modelsLarge population cohortCardiovascular comorbiditiesEchocardiographic studyValve stenosisMass indexClinical burdenClinical variablesUnique patientsC-statisticCare centerMale genderPatient riskComorbidity variablesC-indexMultivariable modelInclusion criteriaTricuspid and mitral remodelling in atrial fibrillation: a three-dimensional echocardiographic study
Ortiz-Leon XA, Posada-Martinez EL, Trejo-Paredes MC, Ivey-Miranda JB, Pereira J, Crandall I, DaSilva P, Bouman E, Brooks A, Gerardi C, Houle H, Hur DJ, Lin BA, McNamara RL, Lombo-Lievano B, Akar JG, Arias-Godinez JA, Sugeng L. Tricuspid and mitral remodelling in atrial fibrillation: a three-dimensional echocardiographic study. European Heart Journal - Cardiovascular Imaging 2022, 23: 944-955. PMID: 35243501, DOI: 10.1093/ehjci/jeac045.Peer-Reviewed Original ResearchConceptsAtrial fibrillationMitral annulusVentricular functionLV functionSinus rhythmThree-dimensional echocardiographic studyImpact of AFNon-valvular atrial fibrillationNormal left ventricular functionTricuspid annulus dilationLV systolic dysfunctionNormal LV functionLeft ventricular functionAbnormal ventricular functionMA dilationTA dilationSystolic dysfunctionFunctional regurgitationAtrial enlargementEchocardiographic studyTransoesophageal echocardiographyAF groupAnnulus dilationAtrioventricular valvePatients
2020
Impact of Tricuspid Valve Repair for Moderate Tricuspid Regurgitation at the Time of Left Ventricular Assist Device Implantation on the Occurrence of Right Heart Failure
Barac Y, Bishawi M, Milano C, Schroder J, Daneshmand M, Hashmi N, Velazquez E, Rogers J, Patel C, Nicoara A. Impact of Tricuspid Valve Repair for Moderate Tricuspid Regurgitation at the Time of Left Ventricular Assist Device Implantation on the Occurrence of Right Heart Failure. The Journal Of Heart And Lung Transplantation 2020, 39: s444. DOI: 10.1016/j.healun.2020.01.259.Peer-Reviewed Original ResearchRight heart failureModerate tricuspid regurgitationLeft ventricular assist device implantationLate right heart failureVentricular assist device implantationAssist device implantationTricuspid regurgitationTricuspid valve repairLVAD implantationTVR groupTR repairEchocardiographic studyHeart failureStudy cohortDevice implantationValve repairDurable left ventricular assist device implantationEvent-free survival differencesImprovement of TRRight ventricular assist deviceDurable LVAD implantationSevere tricuspid regurgitationSignificant tricuspid regurgitationSingle-center studyKaplan-Meier curves
2016
AGE-GENDER PREDICTED EXERCISE CAPACITY PROVIDES INCREMENTAL PROGNOSTIC UTILITY IN PATIENTS WITH ≥3+ AORTIC REGURGITATION AND PRESERVED LEFT VENTRICULAR SYSTOLIC FUNCTION AND DIMENSIONS: AN EXERCISE ECHOCARDIOGRAPHIC STUDY
Mentias A, Alashi A, Feng K, Rodriguez L, Gillinov A, Sabik J, Svensson L, Griffin B, Desai M. AGE-GENDER PREDICTED EXERCISE CAPACITY PROVIDES INCREMENTAL PROGNOSTIC UTILITY IN PATIENTS WITH ≥3+ AORTIC REGURGITATION AND PRESERVED LEFT VENTRICULAR SYSTOLIC FUNCTION AND DIMENSIONS: AN EXERCISE ECHOCARDIOGRAPHIC STUDY. Journal Of The American College Of Cardiology 2016, 67: 1650. DOI: 10.1016/s0735-1097(16)31651-5.Peer-Reviewed Original Research
2008
Prognostic Implications of Left Ventricular Mass and Geometry Following Myocardial Infarction The VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study
Verma A, Meris A, Skali H, Ghali JK, Arnold JM, Bourgoun M, Velazquez EJ, McMurray JJ, Kober L, Pfeffer MA, Califf RM, Solomon SD. Prognostic Implications of Left Ventricular Mass and Geometry Following Myocardial Infarction The VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study. JACC Cardiovascular Imaging 2008, 1: 582-591. PMID: 19356485, DOI: 10.1016/j.jcmg.2008.05.012.Peer-Reviewed Original ResearchMeSH KeywordsAgedAngiotensin II Type 1 Receptor BlockersCardiovascular DiseasesEuropeFemaleHeart VentriclesHumansHypertrophy, Left VentricularKaplan-Meier EstimateMaleMiddle AgedMyocardial InfarctionPredictive Value of TestsProportional Hazards ModelsRecurrenceRisk AssessmentRisk FactorsTetrazolesTime FactorsTreatment OutcomeUltrasonographyUnited StatesValineValsartanVentricular RemodelingConceptsLeft ventricular mass indexRelative wall thicknessHigh-risk myocardial infarctionAdverse cardiovascular eventsLeft ventricular massMyocardial infarctionLV geometryCardiovascular eventsConcentric remodelingEchocardiographic studyLV hypertrophyConcentric hypertrophyEccentric hypertrophyPrognostic implicationsVentricular massBaseline left ventricular mass indexMean left ventricular mass indexBaseline left ventricular massHigher relative wall thicknessBaseline LV massNonfatal cardiovascular outcomesAbnormal LV geometryComposite end pointVentricular mass indexConcentric LV hypertrophy
2006
Comparison of Regional Versus Global Assessment of Left Ventricular Function in Patients with Left Ventricular Dysfunction, Heart Failure, or Both After Myocardial Infarction: The Valsartan in Acute Myocardial Infarction Echocardiographic Study
Thune JJ, Køber L, Pfeffer MA, Skali H, Anavekar NS, Bourgoun M, Ghali JK, Arnold JM, Velazquez EJ, Solomon SD. Comparison of Regional Versus Global Assessment of Left Ventricular Function in Patients with Left Ventricular Dysfunction, Heart Failure, or Both After Myocardial Infarction: The Valsartan in Acute Myocardial Infarction Echocardiographic Study. Journal Of The American Society Of Echocardiography 2006, 19: 1462-1465. PMID: 17138030, DOI: 10.1016/j.echo.2006.05.028.Peer-Reviewed Original ResearchMeSH KeywordsAgedAntihypertensive AgentsComorbidityEchocardiographyFemaleHeart FailureHumansInternationalityMaleMiddle AgedMyocardial InfarctionPrevalencePrognosisReproducibility of ResultsRisk AssessmentRisk FactorsSensitivity and SpecificityStroke VolumeTetrazolesValineValsartanVentricular Dysfunction, LeftConceptsWall motion indexMyocardial infarctionHeart failureLV dysfunctionEjection fractionIndependent predictorsGlobal assessmentLeft ventricular dysfunctionLV systolic functionVentricular ejection fractionAdditional prognostic informationLeft ventricular functionAcute myocardial infarctionBiplane Simpson's ruleWall motion assessmentVentricular dysfunctionSystolic functionEchocardiographic studyVentricular functionMultivariable analysisPrognostic valueAdverse outcomesPrognostic informationLVEFRegional dysfunction
2004
Importance of echocardiography in patients with severe nonischemic heart failure: the second prospective randomized amlodipine survival evaluation (PRAISE-2) echocardiographic study
Cabell CH, Trichon BH, Velazquez EJ, Dumesnil JG, Anstrom KJ, Ryan T, Miller AB, Belkin RN, Cropp AB, O'Connor CM, Jollis JG. Importance of echocardiography in patients with severe nonischemic heart failure: the second prospective randomized amlodipine survival evaluation (PRAISE-2) echocardiographic study. American Heart Journal 2004, 147: 151-157. PMID: 14691434, DOI: 10.1016/j.ahj.2003.07.010.Peer-Reviewed Original ResearchConceptsHeart failureEchocardiographic studyEchocardiographic parametersNonischemic cardiomyopathyEchocardiographic examinationPrognostic informationClinical informationRestrictive left ventricular filling patternLeft ventricular filling patternSevere nonischemic heart failureAvailable echocardiographic parametersBaseline clinical findingsVentricular filling patternSignificant clinical predictorsIncremental prognostic informationClinical examination findingsImportance of echocardiographyNonischemic heart failureVentricular ejection fractionEchocardiographic predictorsClinical predictorsEchocardiographic measuresEjection fractionExamination findingsClinical findings
1984
Intraventricular hemorrhage in the preterm neonate: Timing and cerebral blood flow changes
Ment L, Duncan C, Ehrenkranz R, Lange R, Taylor K, Kleinman C, Scott D, Sivo J, Gettner P. Intraventricular hemorrhage in the preterm neonate: Timing and cerebral blood flow changes. The Journal Of Pediatrics 1984, 104: 419-425. PMID: 6707798, DOI: 10.1016/s0022-3476(84)81109-9.Peer-Reviewed Original ResearchConceptsGMH/IVHCerebral blood flowPostnatal hoursBlood flowEarly hemorrhagePreterm neonatesIntraventricular hemorrhageIVH groupUltrasound studyLow cerebral blood flowCerebral blood flow changesCerebral blood flow determinationsCranial ultrasound studiesHigh ventilator settingsCerebral blood flow valuesPatent ductus arteriosusBlood flow changesRisk factor analysisBlood flow determinationsBlood flow valuesTime of birthVigorous resuscitationNeonatal eventsDuctus arteriosusEchocardiographic study
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply